Table 8.
Unsaturated acylcarnitine levels stratified by sex and OCs use
| Men (n=41) | Women (n=43) | Women OCs (n=26) | |
|---|---|---|---|
| C5:1 (μM) | 0.04 (0.03-0.07) | 0.03 (0.01-0.06) | 0.03 (0.02-0.08) |
| C6:1 (μM) | 0.2 (0.09-0.4) | 0.1 (0.07-0.4) | 0.2 (0.1-0.5) |
| C8:1 (μM) | 0.14 (0.07-0.5) | 0.11 (0.05-0.3) | 0.15 (0.09-0.4) |
| C10:1 (μM) | 0.2 (0.1-0.5) | 0.2 (0.04-0.5) | 0.2 (0.1-0.3) |
| C10:2 (μM) | 0.07 (0.03-0.2) | 0.05 (0.02-0.1) | 0.09 (0.03-0.2) |
| C12:1 (μM) | 0.09 (0.04-0.2) | 0.09 (0.03-0.2) | 0.09 (0.05-0.2) |
| C14:1 (μM) | 0.10 (0.03-0.2) | 0.09 (0.02-0.3) | 0.07 (0.01-0.2) |
| C14:2 (μM) | 0.09 (0.05-0.2) | 0.07 (0.03-0.1) | 0.08 (0.05-0.2) |
| C16:1 (μM) | 0.05±0.01 | 0.04±0.01 | 0.05±0.02 |
| C18:1 (μM) | 0.16±0.06 | 0.15±0.05 | 0.14±0.05 |
| C18:2 (μM) | 0.08±0.03 | 0.06±0.02 | 0.06±0.02 |
Values are expressed as the mean±standard deviation or as the median (range). n=number of subjects.